Cardiometabolic Health Congress

JANUARY 15, 2025

Atherosclerosisa key driver of cardiovascular disease (CVD)continues to be a significant global health issue. For example, the global spread of obesity, particularly among youth, has set the stage for a future pandemic of non-communicable diseases.

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

Cardiometabolic Health Congress

FEBRUARY 1, 2024

Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovascular disease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91 million globally.

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

JAMA Cardiology

APRIL 6, 2024

This secondary analysis of a randomized clinical trial examines the antibody response to high-dose trivalent compared with standard-dose quadrivalent inactivated influenza vaccine in patients with a recent acute myocardial infarction or heart failure hospitalization.

Cardiovascular Disease 89

Cardiovascular Disease Myocardial Infarction Heart Failure Hospital 89

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundIn patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The primary effectiveness end point was death from any cause, hospitalization for myocardial infarction, or hospitalization for stroke.

Cardiovascular Disease 74

Cardiovascular Disease Myocardial Infarction Hospital Stroke 74

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Cardiovascular magnetic (CMR) resonance is a versatile tool for diagnosing cardiovascular diseases. This has led to a growing interest in developing artificial intelligence (AI)-powered CMR techniques for MI detection without contrast agents.

Myocardial Infarction 52

Myocardial Infarction Cardiovascular Disease 52

Hypertension Journal

FEBRUARY 22, 2024

In modeling, the risk for any cardiovascular disease event among women with a history of hypertensive disorders of pregnancy was generally 10% to 20% higher, with main models estimating hazard ratios to 1.20 (95% CI, 0.99–1.47) Hypertension, Ahead of Print. years for women with type 1 and 29.8 years for women with type 2 diabetes.

Cardiovascular Disease 74

Cardiovascular Disease Hypertension Diabetes Myocardial Infarction 74

American College of Cardiology

APRIL 7, 2025

Chronic inflammation plays a role in the pathogenesis of cardiovascular diseases, including atherosclerosis, pericarditis, stroke, and myocardial infarction (MI).

Atherosclerosis 69

Atherosclerosis Myocardial Infarction Pericarditis Cardiovascular Disease 69

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Cardiovascular diseases (CVDs) still maintain high morbidity and mortality globally. Helicases, a unique class of enzymes, are extensively implicated in the processes of nucleic acid (NA) metabolism across various organisms. They play a pivotal role in gene expression, inflammatory response, lipid metabolism, and so forth.

Cardiovascular Disease 64

Cardiovascular Disease Myocardial Infarction Atherosclerosis Cancer 64

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

In recent years, S100 calcium binding protein A8/A9 (S100A8/A9) derived from neutrophils has attracted increasing attention as an important warning protein for cardiovascular disease.

Cardiovascular Disease 52

Cardiovascular Disease Myocardial Infarction Atherosclerosis Biomarkers 52

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Background and objectives Hypertension is one of the most serious risk factors and the leading cause of mortality in patients with cardiovascular diseases (CVDs). It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension. Methods The synopsis of our research is as follows.

Myocardial Infarction 64

Myocardial Infarction Hypertension Risk Factors Cardiovascular Disease 64

Frontiers in Cardiovascular Medicine

AUGUST 6, 2024

Myocardial infarction (MI) stands at top global causes of death in developed countries, owing mostly to atherosclerotic plaque growth and endothelial injury-induced reduction in coronary blood flow. While early reperfusion techniques have improved outcomes, long-term treatment continues to be difficult.

Myocardial Infarction 52

Myocardial Infarction Plaque Physiology Cardiovascular Disease 52

Heart BMJ

JUNE 25, 2024

Background We aimed to investigate the effectiveness of fixed-dose combination therapy (polypill) for primary and secondary prevention of major cardiovascular diseases in a typical rural setting. The Cox regression model, with shared frailty, was used to account for clustering effect. Trial registration number NCT03459560.

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Pharmacology Angina 59

Frontiers in Cardiovascular Medicine

JUNE 3, 2024

Indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) serve as the initial and pivotal enzymes of the KP, with IDO playing important and intricate roles in cardiovascular diseases. Multiple studies have indicated that kynurenine (KYN) may serve as a potential biomarker for several adverse cardiovascular events.

Cardiovascular Disease 52

Cardiovascular Disease Atherosclerosis Myocardial Infarction Physiology 52

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2025

BackgroundThe acute myocardial infarction (AMI) is a prevalent and severe cardiovascular disease, characterized by its sudden onset, high mortality rate, and unfavorable prognosis.

Myocardial Infarction 52

Myocardial Infarction Diabetes Heart Failure Laboratory 52

Journal of the American Heart Association

MARCH 27, 2025

BackgroundRecent evidence highlights an increasing incidence of myocardial infarction in young women. years]) admitted to the China Chest Pain Center Database between 2016 and 2021.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack 52

Cardiovascular Diabetology

JULY 10, 2024

Background The effect of empagliflozin, a sodium-glucose-co-transporter-2 inhibitor, on risk for myocardial infarction has not been fully characterized.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Bypass Graft Outcomes Plaque 52

Journal of Cardiovascular Pharmacology

APRIL 4, 2024

Myocardial infarction (MI) and pulmonary artery hypertension (PAH) are two prevalent cardiovascular diseases. Pterostilbene (PTE), an antioxidant compound, has been studied as a possible therapy for cardiovascular diseases. In both conditions, oxidative stress is associated with a worse prognosis.

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Disease Pulmonary Hypertension 40

Medical Xpress - Cardiology

APRIL 3, 2024

Cardiovascular diseases, including myocardial infarction and stroke, are the world's leading cause of death, claiming around 18 million lives a year.

Research 83

Research Myocardial Infarction Cardiovascular Disease Stroke 83

American College of Cardiology

JUNE 6, 2024

Is excess apolipoprotein B (apoB) associated with an increased risk of myocardial infarction (MI), atherosclerotic cardiovascular disease (ASCVD), and all-cause mortality?

Myocardial Infarction 68

Myocardial Infarction Cardiovascular Disease Article 68

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundMyocardial infarction is a cardiovascular disease that significantly contributes to global morbidity and disability. Univariate Mendelian analyses revealed genetic associations among 9 categories of dietary habits (83 types) and myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction Cholesterol Diet Risk Factors 40

Frontiers in Cardiovascular Medicine

JUNE 30, 2024

Cardiovascular disease (CVD) represents the leading cause of mortality and disability all over the world. In this article, we first describe how ERK signaling contributes to preserving cardiovascular health.

Cardiovascular Disease 52

Cardiovascular Disease Quality of Life Myocardial Infarction Aneurysm 52

Frontiers in Cardiovascular Medicine

MAY 29, 2024

BackgroundMesenchymal stem cells (MSCs) have important research value and broad application prospects in cardiovascular diseases (CVDs). However, few bibliometric analyses on MSCs in cardiovascular diseases are available.

Cardiovascular Disease 52

Cardiovascular Disease Research Myocardial Infarction Article 52

Journal of the American Heart Association

MARCH 26, 2025

Multivariable logistic regression models were used to estimate BMIstratified associations between SMuRFless status and outcomes.ResultsThe study included 44 538 patients with firstpresentation acute myocardial infarction, of whom 4454 were SMuRFless. Journal of the American Heart Association, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction Risk Factors BMI Obesity 40

Open Heart

JUNE 24, 2022

Objective Short-term ambient fine particulate matter (PM 2.5 ) is associated with adverse cardiovascular events including myocardial infarction (MI). and subclinical cardiomyocyte damage outside of overt cardiovascular events. However, few studies have examined associations between PM 2.5

Myocardial Infarction 52

Myocardial Infarction Biomarkers Cardiovascular Disease 52

Heart BMJ

APRIL 25, 2024

Objective Observational studies show that hypertensive disorders of pregnancy (HDPs) are related to unfavourable maternal cardiovascular disease (CVD) risk profiles later in life. In our primary analysis, we applied Mendelian randomisation using inverse-variance weighted regression analysis in ever pregnant women.

Cardiovascular Disease 52

Cardiovascular Disease Hypertension Blood Pressure Myocardial Infarction 52

Cardiovascular Diabetology

SEPTEMBER 10, 2024

Triglyceride-glucose (TyG) index, a dependable indicator of insulin resistance, has been identified as a valid marker regarding multiple cardiovascular diseases. Nevertheless, the correlation of TyG index with.

Cardiogenic Shock 59

Cardiogenic Shock Myocardial Infarction Cardiovascular Disease Research 59

Frontiers in Cardiovascular Medicine

JUNE 18, 2024

BackgroundSlow flow/no-reflow (SF-NR) during percutaneous coronary intervention (PCI) is associated with poor prognosis of patients with acute myocardial infarction (AMI). Currently, effective treatment is not available for SF-NR. However, its effects on SF-NR in the AMI patients during PCI are not clear.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Laboratory Ischemia 52

HeartRhythm

JANUARY 26, 2024

Sympathetic nervous system hyperactivity plays a major role in the pathogenesis of ventricular arrhythmias following myocardial infarction (MI).1,2 3 Neuroinflammation has been implicated as a mechanism for sympathetic activation in cardiovascular disease.

Arrhythmia 80

Arrhythmia Sudden Cardiac Death Myocardial Infarction Tachycardia 80

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovascular diseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. vs. 53.2%, p  = 0.014) and myocardial infarction (24.7% vs. 5.5.%,

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease 59

BoardVitals - Cardiovascular

AUGUST 7, 2017

Dr. Nilay Mehta, DO works as a cardiovascular disease specialist in Humble, Texas at Memorial Hermann Northeast Hospital. I chose Cardiology because my father had a Myocardial Infarction (MI) at age 49 and it was missed by a cardiologist. Answer : Medicine runs in my family.

Cardiovascular Disease 52

Cardiovascular Disease Myocardial Infarction Certification Blog 52

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

There are several factors which increase the risk of cardiovascular disease in survivors of spinal cord injury. Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk. PMID: 17251696.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure 40

Journal of the American Heart Association

FEBRUARY 28, 2024

We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Stroke 76

Journal of the American Heart Association

MARCH 4, 2025

In congenital heart diseases, SDoHs can affect major outcomes, as well. In congenital heart diseases, SDoHs can affect major outcomes, as well. In conclusion, SDoHs significantly impact cardiovascular morbidity and death and specific outcomes of patients with cardiovascular disease.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40

DAIC

JULY 18, 2024

The lead investigators for the study are Dr. Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link].

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

Journal of the American Heart Association

JANUARY 10, 2025

The primary outcome was risk of an ASCVD hospitalization composite outcome (myocardial infarction, coronary artery bypass graft, percutaneous coronary intervention, stroke, transient ischemic accident) after COPD hospitalization relative to before COPD hospitalization.

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Cardiovascular Disease Hospital Pulmonary 45